Home » Newsletters » BioWorld

BioWorld

June 10, 1994

View Archived Issues

CANGENE'S BOARD TO MEET ON PHARMA PATCH OFFER

CARRINGTON GIVEN OK FOR AIDS TRIAL

MERCK PROVIDES VACCINE TECHNOLOGY TO CHINA

ARRIS FOCUSES ON INHIBITING TRYPTASE

BIOMUNE COMPLETES $5.4M PLACEMENT

NEW COMPANY TO TRANSPLANT HUMAN ISLET CELLS

CAMBRIDGE BIOTECH'S STOCK DELISTED DUE TO AUDIT

LIDAK NETS $8.3M FROM WARRANTS

CLEVELAND CLINIC TURNS RESEARCH INTO ANTISENSE COMPANY

RAC APPROVES GENE THERAPY PROTOCOL FOR ARTHRITIS

FDA PANEL RECOMMENDS APPROVAL OF CENTOCOR'S REOPRO

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...